About the Authors

Jared M. Baeten

jbaeten@uw.edu

Affiliations Department of Global Health, University of Washington, Seattle, Seattle, Washington, United States of America, Department of Medicine, University of Washington, Seattle, Seattle, Washington, United States of America, Department of Epidemiology, University of Washington, Seattle, Seattle, Washington, United States of America

Renee Heffron

Affiliations Department of Global Health, University of Washington, Seattle, Seattle, Washington, United States of America, Department of Epidemiology, University of Washington, Seattle, Seattle, Washington, United States of America

Lara Kidoguchi

Affiliation Department of Global Health, University of Washington, Seattle, Seattle, Washington, United States of America

Nelly R. Mugo

Affiliations Department of Global Health, University of Washington, Seattle, Seattle, Washington, United States of America, Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya

Elly Katabira

Affiliation Infectious Disease Institute, Makerere University, Kampala, Uganda

Elizabeth A. Bukusi

Affiliations Department of Global Health, University of Washington, Seattle, Seattle, Washington, United States of America, Centre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya

Stephen Asiimwe

Affiliation Kabwohe Clinical Research Center, Kabwohe, Uganda

Jessica E. Haberer

Affiliation Massachusetts General Hospital, Boston, Massachusetts, United States of America

Jennifer Morton

Affiliation Department of Global Health, University of Washington, Seattle, Seattle, Washington, United States of America

Kenneth Ngure

Affiliation College of Health Sciences, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya

Nulu Bulya

Affiliation Infectious Disease Institute, Makerere University, Kampala, Uganda

Josephine Odoyo

Affiliation Centre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya

Edna Tindimwebwa

Affiliation Kabwohe Clinical Research Center, Kabwohe, Uganda

Craig Hendrix

Affiliation Department of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America

Mark A. Marzinke

Affiliation Department of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America

Norma C. Ware

Affiliation Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, United States of America

Monique A. Wyatt

Affiliations Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, United States of America, Harvard Global, Cambridge, Massachusetts, United States of America

Susan Morrison

Affiliation Department of Global Health, University of Washington, Seattle, Seattle, Washington, United States of America

Harald Haugen

Affiliation Department of Global Health, University of Washington, Seattle, Seattle, Washington, United States of America

Andrew Mujugira

Affiliation Department of Global Health, University of Washington, Seattle, Seattle, Washington, United States of America

Deborah Donnell

Affiliations Department of Global Health, University of Washington, Seattle, Seattle, Washington, United States of America, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

Connie Celum

Affiliations Department of Global Health, University of Washington, Seattle, Seattle, Washington, United States of America, Department of Medicine, University of Washington, Seattle, Seattle, Washington, United States of America, Department of Epidemiology, University of Washington, Seattle, Seattle, Washington, United States of America

Partners Demonstration Project Team

Membership of the Partners Demonstration Project Team is provided in the Acknowledgments.

Competing Interests

All authors have read the journal's policy and have the following competing interests: Gilead Sciences donated the PrEP medication used in this study. CH received prior funding (05/01/09-04/30/10) for a pharmacokinetics study of TDF in the colon and female genital tract from Gilead Sciences and has a patent pending using a different formulation of the drug used in this study.

Author Contributions

Conceived and designed the experiments: JMB RH CC. Performed the experiments: JMB RH LK NRM EK EAB SA JEH JM KN NB JO ET CH MAM NCW MAW SM HH AM DD CC. Analyzed the data: LK DD. Wrote the first draft of the manuscript: JMB. Contributed to the writing of the manuscript: JMB RH LK NRM EK EAB SA JEH JM KN NB JO ET CH MAM NCW MAW SM HH AM DD CC. Enrolled patients: JMB RH NRM EK EAB SA JM KN NB JO ET SM HH CC. Agree with the manuscript’s results and conclusions: JMB RH LK NRM EK EAB SA JEH JM KN NB JO ET CH MAM NCW MAW SM HH AM DD CC. Contributed to the design of the study and oversaw operations at the study sites: NRM EK EAB SA JM KN JO NB ET SM HH AM. Led adherence measurement and interpretation work: JEH CH MAM NCW MAW. All authors contributed to the execution of the work and all critically reviewed and approved the manuscript. All authors have read, and confirm that they meet, ICMJE criteria for authorship.